⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Consult your healthcare provider before starting any medication.
Getting access to GLP-1 medications in India — semaglutide (Ozempic, Wegovy, Rybelsus) or liraglutide (Victoza, Saxenda) — can feel confusing and overwhelming. These are Schedule H1 drugs, meaning they legally require a prescription from a registered medical practitioner. They cannot be purchased over the counter.
This guide walks you through every step of getting a GLP-1 prescription in India — which doctors to see, what tests you need, what the consultation looks like, costs involved, and the mistakes to avoid.
GLP-1 medications can be prescribed by:
Cannot prescribe: Nutritionists, dietitians, physiotherapists, Ayurvedic practitioners (BAMS), and homeopaths are not authorised to prescribe Schedule H1 drugs.
Practical advice for India: A diabetologist or endocrinologist gives you the best chance of getting a well-monitored prescription with appropriate baseline investigations. General physicians can and do prescribe, but specialist oversight is strongly recommended given the cost and side effect profile of these medications.
Indian doctors typically consider GLP-1 medications for:
For diabetes (Type 2):
For weight loss (obesity):
Important: India's CDSCO has approved semaglutide (Ozempic) for Type 2 diabetes. Wegovy (higher dose semaglutide for weight loss) has approval in some markets but availability and approval status in India should be confirmed with your prescribing doctor. Liraglutide (Saxenda) is approved for chronic weight management.
Coming to your first appointment with recent test results dramatically improves your chances of getting a prescription on the same visit. Recommended tests:
| Test | Why It Is Needed | Normal Range |
|---|---|---|
| HbA1c | Confirms diabetes or pre-diabetes status | Below 5.7% normal; 5.7–6.4% pre-diabetic; above 6.5% diabetic |
| Fasting blood glucose | Blood sugar baseline | 70–100 mg/dL normal |
| Lipid profile | Cardiovascular risk assessment | LDL below 130 mg/dL; triglycerides below 150 mg/dL |
| Serum creatinine + eGFR | Kidney function — critical for GLP-1 safety | eGFR above 30 mL/min typically required |
| Liver function tests (LFTs) | Baseline liver health | Within normal limits |
| TSH (thyroid) | Thyroid status — GLP-1 carries a theoretical thyroid tumour risk, though this has not been demonstrated in humans | Within normal limits |
| Complete blood count (CBC) | General health baseline | Within normal limits |
| Urine routine and microalbuminuria | Early kidney damage screening | No significant proteinuria |
Optional but useful:
Cost of tests in India: A comprehensive panel at a reliable diagnostic lab (Dr Lal PathLabs, SRL, Thyrocare) costs Rs 1,500–4,000 depending on city and tests chosen. Many hospital-attached labs offer packages.
Approach 1: Your existing GP or family doctor If you have an established relationship with a trusted GP, start there. Ask specifically whether they are comfortable prescribing semaglutide or liraglutide for your indication. Many GPs prescribe Victoza (liraglutide) routinely for diabetic patients.
Approach 2: Diabetes or endocrinology OPD at a government hospital Government tertiary hospitals — AIIMS, PGI Chandigarh, JIPMER Puducherry, KEM Mumbai — have diabetes and endocrinology OPDs. Consultation is extremely affordable (Rs 50–500). However, GLP-1 medications are typically not available in government hospital pharmacies and you will need to purchase commercially.
Approach 3: Private diabetologist or endocrinologist Consultation fees in metro cities: Rs 700–2,500 per visit. Most accessible route in tier-1 cities. Doctors in this setting are typically very familiar with GLP-1 medications.
Approach 4: Telemedicine platforms Platforms like Apollo 24/7, Practo, Tata 1mg Doctor, and Lybrate allow you to consult endocrinologists and diabetologists online. For an initial GLP-1 consultation, an in-person visit is strongly preferred — doctors generally want to assess you physically and review test reports in person before prescribing a Schedule H1 drug. Telemedicine may be suitable for follow-up appointments once you are established on treatment.
Red flag: Be cautious of online platforms or WhatsApp-based services offering GLP-1 prescriptions without any clinical evaluation, without reviewing your test reports, or in exchange for upfront payment packages. This is not appropriate medical practice.
A proper first consultation for GLP-1 should take 20–40 minutes and include:
Questions to ask your doctor at this visit:
GLP-1 medications are available at:
Retail pharmacy chains:
Hospital pharmacies:
Online pharmacies:
Pricing (approximate, April 2025):
Cold chain: These medications require refrigeration at 2–8°C. Ensure the pharmacy has proper cold storage. At home, store in the main compartment of the refrigerator, not the freezer door or the vegetable drawer.
A responsible prescribing doctor will schedule follow-up at:
If your doctor does not schedule any follow-up tests after prescribing GLP-1, ask specifically about a monitoring plan.
Buying without a prescription GLP-1 medications are Schedule H1 drugs. Purchasing them without a prescription — including from informal online sources, WhatsApp sellers, or unverified medical tourism routes — is illegal in India and puts you at risk of receiving counterfeit, improperly stored, or incorrectly dosed products.
Self-titrating beyond the prescribed dose Never increase your dose faster than prescribed. If you want to discuss dose escalation, raise it with your doctor — do not do it independently.
Stopping other diabetes medications abruptly If you are on other diabetes medications (metformin, sulphonylureas, insulin), do not stop or reduce them independently when starting GLP-1. Your doctor will advise on any adjustments.
Hiding other medications from your doctor Always disclose all medications — including Ayurvedic or herbal preparations. Some interactions with GLP-1 are clinically significant.
Expecting immediate weight loss GLP-1 medications take weeks to months to show meaningful effect. The first 4 weeks are typically adaptation, not weight loss. Managing expectations is part of appropriate treatment.
Q: My BMI is 26. Can I still get a GLP-1 prescription in India? Possibly, if you have significant comorbidities — PCOS, pre-diabetes, non-alcoholic fatty liver disease (NAFLD), hypertension. Indian metabolic risk occurs at lower BMI thresholds than in Western populations. Discuss your specific situation with a doctor.
Q: Can I get a prescription from a doctor I see only once? Technically yes, but responsible prescribing requires clinical assessment, review of test results, and a follow-up plan. A one-time telehealth visit with no lab review is not appropriate clinical practice.
Q: Are there any government schemes that subsidise GLP-1 costs in India? Currently, GLP-1 medications are not included in any central government health scheme (Ayushman Bharat or CGHS formulary) for weight loss indications. Some state-level schemes may cover them for diabetes. Your doctor can advise on whether corporate insurance or mediclaim policies in India cover GLP-1 medications — coverage is variable and often requires prior authorisation.
Q: Can I get a GLP-1 prescription while pregnant or breastfeeding? No. GLP-1 medications are contraindicated in pregnancy and breastfeeding. If pregnancy is planned, GLP-1 should be stopped at least 2 months before trying to conceive. Always inform your prescribing doctor if there is any chance of pregnancy.
